Literature DB >> 27586189

Extending the Limits of Resection for Colorectal Liver Metastases: Positive Resection Margin and Outcome After Resection of Colorectal Cancer Liver Metastases.

Motaz Qadan1, Michael I D'Angelica2.   

Abstract

Entities:  

Year:  2016        PMID： 27586189      PMCID： PMC5608020          DOI： 10.1007/s11605-016-3253-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  9 in total

1.  Selection for hepatic resection of colorectal liver metastases: expert consensus statement.

Authors:  Reid B Adams; Thomas A Aloia; Evelyne Loyer; Timothy M Pawlik; Bachir Taouli; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2013-02       Impact factor: 3.647

2.  Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Authors:  Timothy M Pawlik; Charles R Scoggins; Daria Zorzi; Eddie K Abdalla; Axel Andres; Cathy Eng; Steven A Curley; Evelyne M Loyer; Andrea Muratore; Gilles Mentha; Lorenzo Capussotti; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

3.  Intraoperative surgical margin re-resection for colorectal liver metastasis: is it worth the effort?

Authors:  Georgios A Margonis; Gaya Spolverato; Yuhree Kim; Aslam Ejaz; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2014-12-02       Impact factor: 3.452

4.  Intraoperative margin re-resection for colorectal liver metastases.

Authors:  Curtis J Wray; Andrew M Lowy; Jeffrey B Matthews; Laura E James; Joshua M Mammen; Kyuran A Choe; Douglas W Hanto; Syed A Ahmad
Journal:  J Surg Educ       Date:  2007 May-Jun       Impact factor: 2.891

5.  Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.

Authors:  Andreas Andreou; Thomas A Aloia; Antoine Brouquet; Paxton V Dickson; Giuseppe Zimmitti; Dipen M Maru; Scott Kopetz; Evelyne M Loyer; Steven A Curley; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2013-06       Impact factor: 12.969

6.  Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.

Authors:  Jason S Gold; Chandrakanth Are; Peter Kornprat; William R Jarnagin; Mithat Gönen; Yuman Fong; Ronald P DeMatteo; Leslie H Blumgart; Michael D'Angelica
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

7.  Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?

Authors:  Eran Sadot; Bas Groot Koerkamp; Julie N Leal; Jinru Shia; Mithat Gonen; Peter J Allen; Ronald P DeMatteo; T Peter Kingham; Nancy Kemeny; Leslie H Blumgart; William R Jarnagin; Michael I DʼAngelica
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

8.  R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?

Authors:  Robbert J de Haas; Dennis A Wicherts; Eduardo Flores; Daniel Azoulay; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

9.  Hepatic parenchymal preservation surgery: decreasing morbidity and mortality rates in 4,152 resections for malignancy.

Authors:  T Peter Kingham; Camilo Correa-Gallego; Michael I D'Angelica; Mithat Gönen; Ronald P DeMatteo; Yuman Fong; Peter J Allen; Leslie H Blumgart; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-12-27       Impact factor: 6.113
  9 in total
  2 in total

1.  Recurrence patterns predict survival after resection of colorectal liver metastases.

Authors:  Geoffrey Yuet Mun Wong; Barend Mol; Nazim Bhimani; Philip de Reuver; Connie Diakos; Mark P Molloy; Thomas J Hugh
Journal:  ANZ J Surg       Date:  2022-06-06       Impact factor: 2.025

2.  Weight Loss Following Hepatopancreatobiliary Surgery. How Much is Too Much? A Retrospective Cohort Study.

Authors:  Betty H Zhang; Sanaa Ghazi Faisal; Leyo Ruo; Marko Simunovic; Maria I Pinto-Sanchez; Pablo E Serrano
Journal:  Surg Innov       Date:  2021-07-19       Impact factor: 1.785
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.